Metropolis Healthcare Ltd - 542650 - Corporate Action-Board to consider Dividend
This is to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Friday, February 11, 2022 through Video Conferencing to inter-alia, Consider the proposal for declaration of an Interim Dividend for the Financial Year 2021-22, if any. Metropolis Healthcare Ltd - 542650 - Board Meeting Intimation for Intimation Of Notice Of Board Meeting To Be Held On Friday, February 11, 2022
Metropolis Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2022 ,inter alia, to consider and approve 1. Consider and approve the Unaudited Standalone & Consolidated Financial Results of the Company for the quarter and nine months ended December 31, 2021. 2. Consider the proposal for declaration of an Interim Dividend for the Financial Year 2021-22, if any. Metropolis Healthcare Ltd - 542650 - Intimation Of Record Date For Interim Dividend
The Record date for the purpose of determining eligibility of Members entitled to receive Interim Dividend, if any, shall be Tuesday, February 22, 2022 subject to the approval of the Board
Metropolis is focusing on expanding to smaller cities in 2022: Ameera Shah
Ameera Shah, Promoter and Managing Director, Metropolis Healthcare Ltd, in a candid conversation with Business Today, talked about the diagnostics sector meeting the rising demands of COVID-19 testing, and expansion plans of the company. Metropolis Healthcare Ltd - 542650 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Dear Sir/Madam, We herewith enclose a Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for quarter ended December 31, 2021 received from Link Intime India Private Limited, Registrar & Share Transfer Agent of the Company. Metropolis Healthcare Ltd - 542650 - Statement Of Investor Complaints For The Quarter Ended December 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Ms Simmi Singh BishtDesignation :- Company Secretary and Compliance Officer Metropolis Healthcare Ltd - 542650 - Shareholding for the Period Ended December 31, 2021
Metropolis Healthcare Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2021. For more details, kindly Click here Metropolis Healthcare Ltd - 542650 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Dear Sir / Madam, With reference to the captioned subject, we wish to inform you that the Nomination and Remuneration Committee of the Board of Directors of the Company has on January 05, 2022 approved the allotment of 1626 (One Thousand Six Hundred and Twenty-Six) Equity Shares of Rs. 2/- (Rupees Two Only) each at an Exercise price of Rs. 2/- (Rupees Two Only) per Equity Share aggregating to Rs. 3252/- (Three Thousand Two Hundred and Fifty-Two Only) to the eligible employees of the Company who have exercised their stock units pursuant to Metropolis -Restrictive Stock Unit Plan, 2020 ("MHL-RSU Plan 2020"). The said shares shall rank pari passu in all respects with the existing Equity shares of the Company. Metropolis Healthcare Ltd - 542650 - Closure of Trading Window
This is to inform you that pursuant to the Company's Code of Fair Disclosure of Unpublished Price Sensitive Information framed pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, as amended, the Trading window for dealing in securities of the Company by the Designated Persons of the Company and / or their immediate relatives will be closed with effect from January 01, 2022 and shall remain closed up to 48 ( Forty Eight ) hours after the declaration of the Financial Results of the Company for the quarter and nine months ending December 31, 2021. The date of the Board meeting for approval of financial results of the Company for the quarter and nine months ending December 31, 2021 shall be intimated in due course Metropolis Healthcare Ltd - 542650 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Analyst / Institutional Investor meeting on December 15, 2021